These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3825224)

  • 61. Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.
    Senges J; Lengfelder W; Jauernig R; Czygan E; Brachmann J; Rizos I; Cobbe S; Kübler W
    Circulation; 1984 Mar; 69(3):577-84. PubMed ID: 6692518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term efficacy of antitachycardia pacing for supraventricular and ventricular tachycardias.
    Fisher JD; Johnston DR; Furman S; Mercando AD; Kim SG
    Am J Cardiol; 1987 Dec; 60(16):1311-6. PubMed ID: 3687782
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Verapamil and ventricular tachycardias.
    Tai YT; Chow WH; Lau CP; Yau CC
    Chin Med J (Engl); 1991 Jul; 104(7):567-72. PubMed ID: 1879219
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanism of action of sotalol in supraventricular arrhythmias.
    Brugada P; Smeets JL; Brugada J; Farré J
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():619-23. PubMed ID: 2275892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Reproducible ventricular flutter during programming of a DDD pacemaker].
    Bienstein B; Grosse-Heitmeyer W; Liebetrau M; Stauff L
    Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1889-92. PubMed ID: 8287779
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship between QT interval duration and electrical induction of ventricular tachycardia.
    Dabrowski A; Kolodziej P; Krupienicz A
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):366-9. PubMed ID: 1706854
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The clinical cardiac electrophysiologic effects of tetrandrine].
    Li WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug; 21(4):225-6, 254. PubMed ID: 8194436
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Incidence and significance of inducible supraventricular tachyarrhythmias in patients with chronic myocardial infarction.
    Brembilla-Perrot B; de la Chaise AT; Lessa de Souza M; Bailly L
    Eur Heart J; 1991 Mar; 12(3):401-4. PubMed ID: 2040323
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of oral sotalol on systemic hemodynamics and programmed electrical stimulation in patients with ventricular arrhythmias and structural heart disease.
    Winters SL; Kukin M; Pe E; Stewart D; Deitchman D; Gomes JA
    Am J Cardiol; 1993 Aug; 72(4):38A-43A. PubMed ID: 8346725
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time.
    Kus T; Dubuc M; Lambert C; Shenasa M
    J Am Coll Cardiol; 1990 Nov; 16(5):1229-37. PubMed ID: 2229772
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
    Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M
    J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute and chronic effects of sotalol and propranolol on ventricular repolarization using constant-rate pacing.
    Creamer JE; Nathan AW; Shennan A; Camm AJ
    Am J Cardiol; 1986 May; 57(13):1092-6. PubMed ID: 3518383
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rate-dependent failure of ventricular capture in patients treated with oral propafenone.
    Soriano J; Almendral J; Arenal A; San Román D; Delcan JL; Josephson ME
    Eur Heart J; 1992 Feb; 13(2):269-74. PubMed ID: 1555627
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sotalol: a rescue drug in the face of life-threatening refractory ventricular tachycardia.
    Kandasamy A; Arumugham S; Krupanandha H; Reddy B
    Ann Card Anaesth; 2014; 17(2):170-2. PubMed ID: 24732625
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing.
    Blomström-Lundqvist C; Dohnal M; Hirsch I; Lindblad A; Hjalmarson A; Olsson SB; Edvardsson N
    Br Heart J; 1986 Feb; 55(2):181-6. PubMed ID: 3080012
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Induction of electrical heterogeneity impairs ventricular defibrillation: an effect specific to regional conduction velocity slowing.
    Ujhelyi MR; Sims JJ; Miller AW
    Circulation; 1999 Dec 21-28; 100(25):2534-40. PubMed ID: 10604892
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Verapamil in ventricular tachycardia.
    Hasin Y; Kriwisky M; Gotsman MS
    Cardiology; 1984; 71(4):199-206. PubMed ID: 6478466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Refractoriness as a determinant of tachycardia inducibility in the right ventricle.
    Somberg JC; Schwartz J
    Am Heart J; 1987 Aug; 114(2):311-4. PubMed ID: 3604887
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Termination of sustained tachycardia by external noninvasive pacing.
    Luck JC; Davis D
    Pacing Clin Electrophysiol; 1987 Sep; 10(5):1125-9. PubMed ID: 2444936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.